In MV4-11 rat xenografts, continuous intravenous EPZ-5676 at 70 mg/kg/day for 21 days produced complete tumor regressions. At 35 mg/kg/day continuously, or 67 mg/kg/day infused for 8 hours daily, the response was tumor stasis with subsequent regrowth. Efficacy depended on exposure schedule in this model. [1]
In a separate OCI-AML3 DNMT3A-mutant AML rat xenograft study, continuous intravenous EPZ-5676 for 21 days inhibited tumor growth, with statistical significance reported at 70 mg/kg/day. The 35 mg/kg/day cohort did not establish the same significant response; complete regression was not reported for this experiment. [3]
Continuous versus intermittent infusion in MV4-11 rat xenografts
Animal study · Subcutaneous MV4-11 human leukemia xenografts in female athymic nude rats (rnu/rnu) [1]
The first efficacy experiment compared two continuous doses, an intermittent schedule and vehicle. Durable regression at the higher continuous dose contrasted with less durable stasis in other treatment groups.
Conditions shared by the study groups
- Route
- Intravenous infusion
- Treatment course
- 21 days
- Vehicle
- 5% hydroxypropyl-β-cyclodextrin in saline
- Vehicle control
- Model: Subcutaneous MV4-11 human leukemia xenografts in female athymic nude rats (rnu/rnu)
- Frequency: Continuous infusion
- Continuous EPZ-5676, 70 mg/kg/day
- Model: Subcutaneous MV4-11 human leukemia xenografts in female athymic nude rats (rnu/rnu)
- Frequency: Continuous, 24 hours/day
- Continuous EPZ-5676, 35 mg/kg/day
- Model: Subcutaneous MV4-11 human leukemia xenografts in female athymic nude rats (rnu/rnu)
- Frequency: Continuous, 24 hours/day
- Intermittent EPZ-5676, 67 mg/kg/day
- Model: Subcutaneous MV4-11 human leukemia xenografts in female athymic nude rats (rnu/rnu)
- Frequency: 8 hours/day
Methods and source locations
Compound reported in the paper: EPZ-5676 (pinometostat); Compound label in the paper: EPZ-5676
Preclinical ectopic rat xenograft response, without clinical efficacy inference.
Figure 5A and caption; first efficacy Results; Rat MV4-11 xenograft methods
Tumor volume relative to vehicle: Median tumor sizes, n = 10 per group; repeated-measures ANOVA with Dunnett posttest. No volume decimals inferred from curves. — Figure 5A and caption; first efficacy Results; Rat MV4-11 xenograft methods
Vehicle control · Figure 5A and caption; first efficacy Results; Rat MV4-11 xenograft methods
Continuous EPZ-5676, 70 mg/kg/day · Figure 5A and caption; first efficacy Results; Rat MV4-11 xenograft methods
Continuous EPZ-5676, 35 mg/kg/day · Figure 5A and caption; first efficacy Results; Rat MV4-11 xenograft methods
Intermittent EPZ-5676, 67 mg/kg/day · Figure 5A and caption; first efficacy Results; Rat MV4-11 xenograft methods
Tumor-growth inhibition in DNMT3A-mutant OCI-AML3 rat xenografts
Animal study · Subcutaneous OCI-AML3 DNMT3A-mutant AML xenografts in female athymic nude rats (Hsd:RH-Foxn1rnu) [3]
Dose-dependent tumor-growth inhibition reached significance at 70 mg/kg/day. Activity in this second leukemia model does not imply uniform genotype-independent responses.
Conditions shared by the study groups
- Route
- Intravenous infusion
- Frequency
- Continuous infusion
- Treatment course
- 21 days, followed by 7-day drug holiday
- Vehicle
- 5% hydroxypropyl-β-cyclodextrin in saline
- Vehicle control
- Model: Subcutaneous OCI-AML3 DNMT3A-mutant AML xenografts in female athymic nude rats (Hsd:RH-Foxn1rnu)
- EPZ-5676, 35 mg/kg/day
- Model: Subcutaneous OCI-AML3 DNMT3A-mutant AML xenografts in female athymic nude rats (Hsd:RH-Foxn1rnu)
- EPZ-5676, 70 mg/kg/day
- Model: Subcutaneous OCI-AML3 DNMT3A-mutant AML xenografts in female athymic nude rats (Hsd:RH-Foxn1rnu)
Methods and source locations
Compound reported in the paper: EPZ-5676 (pinometostat); Compound label in the paper: EPZ-5676
Rat tumor-growth result only; not a claim about primary human AML samples or an Adooq lot.
Cell culture and reagents; Nude rat xenografts, efficacy cohort; in-vivo efficacy Results; Figure 6C and caption
OCI-AML3 tumor growth relative to vehicle: N = 8 animals/cohort; error bars are SD. General statistics list Student t test and one-way ANOVA without exact test assignment to this panel. — Cell culture and reagents; Nude rat xenografts, efficacy cohort; in-vivo efficacy Results; Figure 6C and caption
Vehicle control · Cell culture and reagents; Nude rat xenografts, efficacy cohort; in-vivo efficacy Results; Figure 6C and caption
EPZ-5676, 35 mg/kg/day · Cell culture and reagents; Nude rat xenografts, efficacy cohort; in-vivo efficacy Results; Figure 6C and caption
EPZ-5676, 70 mg/kg/day · Cell culture and reagents; Nude rat xenografts, efficacy cohort; in-vivo efficacy Results; Figure 6C and caption